Use of the FebriDx Point-of-care Test for Lower Respiratory Tract Infections in Primary Care: a Qualitative Interview Study

Overview

Journal BJGP Open

Specialty Public Health

Date 2024 Apr 30

PMID 38688532

Authors

Jill Rutter

Christopher R Wilcox

Nour Odeh

Ingrid Muller

Tristan W Clark

Paul Little

Firoza Davies

John McGavin

Nick Francis

Affiliations

Soon will be listed here.

Abstract

Background: FebriDx is a single-use, analyser-free, point-of-care test with markers for bacterial (C-reactive protein [CRP]) and viral (myxovirus resistance protein A [MxA]) infection, measured on a finger-prick blood sample.

Aim: As part of a larger feasibility study, we explored the views of healthcare professionals (HCPs) and patients on the use of FebriDx to safely reduce antibiotic prescriptions for lower respiratory tract infections (LRTIs) in primary care.

Design & Setting: Remote semi-structured qualitative interviews were conducted in South England.

Method: In total, 22 individuals (12 patients who underwent FebriDx testing and 10 HCPs from general practices that conducted testing) participated in interviews, which were analysed thematically.

Results: Patients and HCPs expressed positive views about use of the test. They felt FebriDx was a useful tool to inform prescribing decisions and provided a visual aid to support shared decision making and appropriate antibiotic use. Most felt it would be feasible to integrate use into routine primary care consultations. Some practical difficulties with blood collection and interpreting results, which impacted on usability, were identified. Some patients' reactions to negative test results suggested the need for better communication alongside use of the test.

Conclusion: FebriDx was perceived as a useful tool to guide antibiotic prescribing and support shared decision making. Initial practical problems with testing and communicating results are potential barriers to use. Training and practice on using the test and effective communication are likely to be important elements in ensuring patient understanding and satisfaction, and successful adoption.

Citing Articles

Recent updates of interferon-derived myxovirus resistance protein A as a biomarker for acute viral infection.

Abebaw D, Akelew Y, Adugna A, Teffera Z, Belew H, Selabat B Eur J Med Res. 2024; 29(1):612.

PMID: 39710743 PMC: 11665083. DOI: 10.1186/s40001-024-02221-8.

References

Mitchell W . Positive language leads to positive wellbeing. BMJ. 2016; 354:i4426. DOI: 10.1136/bmj.i4426. View

Schols A, Dinant G, Cals J . Point-of-care testing in general practice: just what the doctor ordered?. Br J Gen Pract. 2018; 68(673):362-363. PMC: 6058637. DOI: 10.3399/bjgp18X698033. View

Jones C, Howick J, Roberts N, Price C, Heneghan C, Pluddemann A . Primary care clinicians' attitudes towards point-of-care blood testing: a systematic review of qualitative studies. BMC Fam Pract. 2013; 14:117. PMC: 3751354. DOI: 10.1186/1471-2296-14-117. View

Thomas K . General practice consultations: is there any point in being positive?. Br Med J (Clin Res Ed). 1987; 294(6581):1200-2. PMC: 1246362. DOI: 10.1136/bmj.294.6581.1200. View

Dolk F, Pouwels K, Smith D, Robotham J, Smieszek T . Antibiotics in primary care in England: which antibiotics are prescribed and for which conditions?. J Antimicrob Chemother. 2018; 73(suppl_2):ii2-ii10. PMC: 5890730. DOI: 10.1093/jac/dkx504. View

Cooke J, Llor C, Hopstaken R, Dryden M, Butler C . Respiratory tract infections (RTIs) in primary care: narrative review of C reactive protein (CRP) point-of-care testing (POCT) and antibacterial use in patients who present with symptoms of RTI. BMJ Open Respir Res. 2020; 7(1). PMC: 7476490. DOI: 10.1136/bmjresp-2020-000624. View

Coenen S, Francis N, Kelly M, Hood K, Nuttall J, Little P . Are patient views about antibiotics related to clinician perceptions, management and outcome? A multi-country study in outpatients with acute cough. PLoS One. 2013; 8(10):e76691. PMC: 3806785. DOI: 10.1371/journal.pone.0076691. View

Rhedin S, Eklundh A, Ryd-Rinder M, Peltola V, Waris M, Gantelius J . Myxovirus resistance protein A for discriminating between viral and bacterial lower respiratory tract infections in children - The TREND study. Clin Microbiol Infect. 2022; 28(9):1251-1257. DOI: 10.1016/j.cmi.2022.05.008. View

John A, Hopstaken R, Tirimacco R, Audehm R, Price C . Implementing point-of-care CRP testing for better diagnosis of acute respiratory infections. Br J Gen Pract. 2022; 72(715):87-88. PMC: 8813101. DOI: 10.3399/bjgp22X718517. View

10.

Shapiro N, Filbin M, Hou P, Kurz M, Han J, Aufderheide T . Diagnostic Accuracy of a Bacterial and Viral Biomarker Point-of-Care Test in the Outpatient Setting. JAMA Netw Open. 2022; 5(10):e2234588. PMC: 9579916. DOI: 10.1001/jamanetworkopen.2022.34588. View

11.

Smieszek T, Pouwels K, Dolk F, Smith D, Hopkins S, Sharland M . Potential for reducing inappropriate antibiotic prescribing in English primary care. J Antimicrob Chemother. 2018; 73(suppl_2):ii36-ii43. PMC: 5890667. DOI: 10.1093/jac/dkx500. View

12.

Sim T, Chalmers L, Czarniak P, Hughes J, Iacob R, Lee Y . Point-of-care C-reactive protein testing to support the management of respiratory tract infections in community pharmacy: A feasibility study. Res Social Adm Pharm. 2021; 17(10):1719-1726. DOI: 10.1016/j.sapharm.2021.01.004. View

13.

Clark T, Brendish N, Poole S, Naidu V, Mansbridge C, Norton N . Diagnostic accuracy of the FebriDx host response point-of-care test in patients hospitalised with suspected COVID-19. J Infect. 2020; 81(4):607-613. PMC: 7306108. DOI: 10.1016/j.jinf.2020.06.051. View

14.

Shehadeh M, Suaifan G, Hammad E . Active educational intervention as a tool to improve safe and appropriate use of antibiotics. Saudi Pharm J. 2016; 24(5):611-615. PMC: 5059833. DOI: 10.1016/j.jsps.2015.03.025. View

15.

Tonkin-Crine S, Anthierens S, Francis N, Brugman C, Fernandez-Vandellos P, Krawczyk J . Exploring patients' views of primary care consultations with contrasting interventions for acute cough: a six-country European qualitative study. NPJ Prim Care Respir Med. 2014; 24:14026. PMC: 4373386. DOI: 10.1038/npjpcrm.2014.26. View

16.

Mansbridge C, Tanner A, Beard K, Borca F, Phan H, Brendish N . FebriDx host response point-of-care testing improves patient triage for coronavirus disease 2019 (COVID-19) in the emergency department. Infect Control Hosp Epidemiol. 2022; 43(8):979-986. PMC: 8828393. DOI: 10.1017/ice.2021.531. View

17.

Huddy J, Ni M, Barlow J, Majeed A, Hanna G . Point-of-care C reactive protein for the diagnosis of lower respiratory tract infection in NHS primary care: a qualitative study of barriers and facilitators to adoption. BMJ Open. 2016; 6(3):e009959. PMC: 4785316. DOI: 10.1136/bmjopen-2015-009959. View

18.

Lingervelder D, Koffijberg H, Emery J, Fennessy P, Price C, van Marwijk H . How to Realize the Benefits of Point-of-Care Testing at the General Practice: A Comparison of Four High-Income Countries. Int J Health Policy Manag. 2021; 11(10):2248-2260. PMC: 9808289. DOI: 10.34172/ijhpm.2021.143. View

19.

Anthierens S, Tonkin-Crine S, Cals J, Coenen S, Yardley L, Brookes-Howell L . Clinicians' views and experiences of interventions to enhance the quality of antibiotic prescribing for acute respiratory tract infections. J Gen Intern Med. 2014; 30(4):408-16. PMC: 4370987. DOI: 10.1007/s11606-014-3076-6. View

20.

Joseph P, Godofsky E . Outpatient Antibiotic Stewardship: A Growing Frontier-Combining Myxovirus Resistance Protein A With Other Biomarkers to Improve Antibiotic Use. Open Forum Infect Dis. 2018; 5(2):ofy024. PMC: 5815119. DOI: 10.1093/ofid/ofy024. View